Investment Analysts’ updated eps estimates for Wednesday, August 19th:
Cantor Fitzgerald started coverage on shares of AgomAb Therapeutics (NASDAQ:AGMB). The firm issued an overweight rating on the stock.
Wedbush initiated coverage on shares of Aktis Oncology (NASDAQ:AKTS). Wedbush issued an outperform rating and a $35.00 price target on the stock.
Angling Direct (LON:ANG) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 78 target price on the stock.
APA (NASDAQ:APA) was upgraded by analysts at Argus from a hold rating to a buy rating. The firm currently has $48.00 price target on the stock.
AvalonBay Communities (NYSE:AVB) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $190.00 target price on the stock.
AstraZeneca (LON:AZN) had its sell rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a £115 price target on the stock.
BHP Group (LON:BHP) had its hold rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 3,400 target price on the stock.
BHP Group (LON:BHP) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 2,700 price target on the stock.
BMO Capital Markets initiated coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN). The firm issued an outperform rating and a $98.00 price target on the stock.
Cerebras Systems (NASDAQ:CBRS) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $300.00 price target on the stock.
Cerebras Systems (NASDAQ:CBRS) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $300.00 price target on the stock.
Cogent Communications (NASDAQ:CCOI) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $9.00 price target on the stock, down from their previous price target of $22.00.
Ciena (NYSE:CIEN) was upgraded by analysts at Northland Securities from a market perform rating to an outperform rating. The firm currently has $500.00 price target on the stock, up from their previous price target of $450.00.
Climb Bio (NASDAQ:CLYM) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $20.00 price target on the stock.
CNH Industrial (NYSE:CNH) had its neutral rating reissued by analysts at DA Davidson. DA Davidson currently has a $12.00 target price on the stock.
DeFi Technologies (NASDAQ:DEFT) was downgraded by analysts at Maxim Group from a buy rating to a hold rating.
Alliance Global Partners started coverage on shares of DarioHealth (NASDAQ:DRIO). The firm issued a buy rating and a $12.00 price target on the stock.
Bright Minds Biosciences (NASDAQ:DRUG) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $145.00 price target on the stock.
Elastic (NYSE:ESTC) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $106.00 price target on the stock.
Diamondback Energy (NASDAQ:FANG) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $216.00 price target on the stock.
Fabrinet (NYSE:FN) was upgraded by analysts at Fox Advisors from an equal weight rating to an overweight rating.
Fortive (NYSE:FTV) had its buy rating reissued by analysts at Argus. Argus currently has a $68.00 target price on the stock.
GE HealthCare Technologies (NASDAQ:GEHC) had its buy rating reissued by analysts at BTIG Research. They currently have a $79.00 price target on the stock.
GSK (LON:GSK) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 2,000 target price on the stock.
Home Depot (NYSE:HD) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $377.00 price target on the stock.
Home Depot (NYSE:HD) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $425.00 target price on the stock.
Home Depot (NYSE:HD) had its sector weight rating reaffirmed by analysts at KeyCorp.
Home Depot (NYSE:HD) had its buy rating reaffirmed by analysts at Argus. Argus currently has a $400.00 target price on the stock.
Iforex Financial Trading Holdings Ltd. Npv (LON:IFRX) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.
IMAX (NYSE:IMAX) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $60.00 target price on the stock.
Infosys (NYSE:INFY) had its hold rating reiterated by analysts at CLSA.
Intuit (NASDAQ:INTU) had its underweight rating reiterated by analysts at Piper Sandler. The firm currently has a $250.00 price target on the stock.
BMO Capital Markets initiated coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS). They issued a market perform rating and a $60.00 price target on the stock.
Ithaca Energy (LON:ITH) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 270 price target on the stock.
Jack Henry & Associates (NASDAQ:JKHY) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $198.00 target price on the stock.
Klarna Group (NYSE:KLAR) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $18.00 target price on the stock, down from their previous target price of $22.00.
Lowe’s Companies (NYSE:LOW) had its neutral rating reaffirmed by analysts at DA Davidson. They currently have a $245.00 target price on the stock.
Mobico Group (LON:MCG) had its hold rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 35 price target on the stock.
Mercury Systems (NASDAQ:MRCY) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $131.00 target price on the stock, up from their previous target price of $126.00.
Mereo BioPharma Group (NASDAQ:MREO) had its underweight rating reiterated by analysts at JPMorgan Chase & Co..
Moderna (NASDAQ:MRNA) was upgraded by analysts at William Blair from a market perform rating to an outperform rating.
Quantinuum (NASDAQ:QNT) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $155.00 target price on the stock.
Rapport Therapeutics (NASDAQ:RAPP) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $65.00 target price on the stock.
Suncrete (NASDAQ:RMIX) had its buy rating reiterated by analysts at B. Riley Financial, Inc.. B. Riley Financial, Inc. currently has a $25.00 target price on the stock, down from their previous target price of $26.00.
Repay (NASDAQ:RPAY) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a $8.00 target price on the stock.
Raymond James Financial, Inc. initiated coverage on shares of Safehold (NYSE:SAFE). They issued a market perform rating on the stock.
Suncor Energy (NYSE:SU) (TSE:SU) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.
Ultimate Products (LON:ULTP) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.
Vast Resources (LON:VAST) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.
Viavi Solutions (NASDAQ:VIAV) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $70.00 target price on the stock.
Weave Communications (NYSE:WEAV) had its hold rating reiterated by analysts at Loop Capital. Loop Capital currently has a $7.40 target price on the stock.
Weave Communications (NYSE:WEAV) had its neutral rating reiterated by analysts at B. Riley Financial, Inc.. B. Riley Financial, Inc. currently has a $7.40 price target on the stock, down from their previous price target of $8.25.
Wipro (NYSE:WIT) had its underperform rating reissued by analysts at CLSA.
Bank of America Corporation assumed coverage on shares of Zoom Communications (NASDAQ:ZM). They issued a buy rating and a $130.00 price target on the stock.
Zscaler (NASDAQ:ZS) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $225.00 price target on the stock.
Receive News & Ratings for AgomAb Therapeutics NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AgomAb Therapeutics NV and related companies with MarketBeat.com's FREE daily email newsletter.
